Kinematica
A Trailblazer in Homogenization

“Homogenizing perfected” aptly describes Kinematica, an industry-machinery manufacturing company, and their gold-standard homogenizer technology. Kinematica has been playing a pivotal role in the thriving field of health and medicine for over 60 years. Homogenization is a crucial process in the pharmaceutical line for stability, but it frequently comes with the challenge of precision and all that coincides with it, such as temperature control, cost, and energy efficiency. Kinematica’s ground-breaking and efficiently precise homogenizer technology overcomes these barriers cost-effectively.

“The core purpose for our organization is summed up under homogenizing perfected for a healthier, tastier, and cleaner world,” says Andreas Niens, CCO at Kinematica.

With four subsidiaries and a strong client base across 75 countries, Kinematica provides homogenizer equipment for multiple purposes such as manufacturing drugs, vaccines, adjuvants, tablet coats, foamed drug blisters, liposomes, and processes in other industries such as the chemical and food industry. Homogenization is an integrated sequence of operations in these industries, particularly in the pharmaceutical industry, and Kinematica’s equipment plays an important role in this series. The company’s kaleidoscope of solutions includes mixers, reactors, pilot plants, dispersers, and high-pressure homogenizers.

A confluence of science and engineering is necessary to develop these machines, for which the company has dedicated teams, the Kinematica science and engineering team.

The Kinematica science team works on ideation, prototyping, and testing the equipment for the customer’s application. This team is well-versed in the science underlying the technology, and upon receiving consumer insights, the team’s “flywheel” kicks into high gear.

Kinematica’s engineering team takes over to integrate the science team’s innovations. The team determines whether the equipment can be used as a stand-alone process or if it can be integrated into the customer’s existing workflow. Engineers at Kinematica ensure that the equipment complies with the complex CGMP processing regulations, machine directive standards, and safety requirements.

The subsequent stage is to manufacture their core technology, which Kinematica does with personalization by incorporating ancillary products such as tanks, load cells, and pumps. The manufacturing team assembles and tests the equipment before shipping it to the client, and also offer to train customers on how to use it.
One example of Kinematica’s outstanding consistency and precision is their service to a client facing difficulty achieving low particle size or low micron area and uniformity. Kinematica shifted the particle size curve and provided five times the sheer impact on particles in a controlled environment compared to their competitors. In another scenario, Kinematica embarked on a sustainability project in which they significantly reduced energy consumption while ensuring speed and efficiency of homogenization.

The core purpose for our organization is summed up under homogenizing perfected, for a healthier, tastier, and cleaner world

Kinematica’s power to control energy output is a significant advantage in the pharmaceutical industry, particularly because higher energy can affect temperature, affecting product quality because the ingredients used are sensitive and expensive.

“A core point that makes us unique is the willingness and readiness to listen to our customers, absorb their information, and then not only fulfil their core expectation but even offer them an improvement, exceeding expectations,” says Niens.

Kinematica’s success in the field is due to its workforce’s wealth of expertise, empirical knowledge, training, and constant attempt to broaden their horizon and stay at the forefront of current events in the pharma world.

With a powerful legacy backed by the mighty hand over science and engineering, Kinematica continues to push the envelope of innovation in the pharmaceutical industry.